University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Vidal, L"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 11.

Harrington, KJ, Karapanagiotou, EM, Roulstone, V, Twigger, KR, White, CL, Vidal, L, Beirne, D, Prestwich, R, Newbold, K, Ahmed, M, Thway, K, Nutting, CM, Coffey, M, Harris, D, Vile, RG, Pandha, HS, DeBono, JS and Melcher, AA (2010) Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers CLINICAL CANCER RESEARCH, 16 (11). pp. 3067-3077.

Gospodinova, N, Ivanov, DA, Anokhin, DV, Mihai, I, Vidal, L, Brun, S, Romanova, J and Tadjer, A (2009) Unprecedented Route to Ordered Polyaniline: Direct Synthesis of Highly Crystalline Fibrillar Films with Strong π-π Stacking Alignment. Macromol Rapid Commun, 30 (1). pp. 29-33.

Vidal, L, Pandha, HS, Yap, TA, White, CL, Twigger, K, Vile, RG, Melcher, A, Coffey, M, Harrington, KJ and DeBono, JS (2008) A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer CLINICAL CANCER RESEARCH, 14 (21). pp. 7127-7137.

White, CL, Twigger, KR, Vidal, L, De Bono, JS, Coffey, M, Heinemann, L, Morgan, R, Merrick, A, Errington, F, Vile, RG, Melcher, AA, Pandha, HS and Harrington, KJ (2008) Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial GENE THERAPY, 15 (12). pp. 911-920.

Errington, F, Steele, L, Prestwich, R, Harrington, KJ, Pandha, HS, Vidal, L, de Bono, J, Selby, P, Coffey, M, Vile, R and Melcher, A (2008) Reovirus activates human dendritic cells to promote innate antitumor immunity JOURNAL OF IMMUNOLOGY, 180 (9). pp. 6018-6026.

Twigger, K, Vidal, L, White, CL, De Bono, JS, Bhide, S, Coffey, M, Thompson, B, Vile, RG, Heinemann, L, Pandha, HS, Errington, F, Melcher, AA and Harrington, KJ (2008) Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy CLINICAL CANCER RESEARCH, 14 (3). pp. 912-923.

Harris, D, Vidal, L, Melcher, A, Newbold, K, Anthony, A, Karavasilis, V, Agarwal, R, White, C, Twigger, K, Coffey, M, Mettinger, K, Thompson, B, Pandha, H, De-Bono, J and Harrington, K (2007) A Phase I study to evaluate the feasibility, safety and biological effects of intratumoural administration of wild-type Reovirus (REOLYSIN (R)) in combination with radiation in patients with advanced malignancies. MOLECULAR CANCER THERAPEUTICS, 6 (12). 3458S-3458S.

Yap, TA, Vidal, L, Pandha, H, Spicer, J, Digue, L, Coffey, M, Thompson, B, Kaye, SB, Harrington, KJ and De-Bono, JS (2006) A phase I study of wild-type reovirus, which selectively replicates in cells expressing activated Ras, administered intravenously to patients with advanced cancer EJC SUPPLEMENTS, 4 (12). p. 108.

Vidal, L, Pandha, H, Spicer, J, Harrington, KJ, Allen, S, Leader, D, Coffey, M, Thompson, B, Kaye, S and De-Bono, J (2006) A phase I study of reolysin given intravenously to patients with advanced malignancies. In: 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, 2006-06-02 - 2006-06-06, Atlanta, GA.

Vidal, L, Twigger, K, White, C, Coffey, M, Thompson, B, De-Bono, J, Pandha, HS, Melcher, A, Kaye, S and Harrington, KJ (2005) Reovirus enhances radiation cytotoxicity in vitro and in vivo. In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, 2005-11-14 - 2005-11-18, Philadelphia, PA.

Vidal, L, Pandha, H, Harrington, K, Fong, P, Shaw, H, Barrett, M, Leader, D, White, C, Twigger, K, Coffey, M, Thompson, B, Kaye, S and De-Bono, J (2005) A phase I study of a wild-type reovirus (Reolysin) given intravenously to patients with advanced malignancies. In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, 2005-11-14 - 2005-11-18, Philadelphia, PA.

This list was generated on Wed Apr 8 16:22:23 2020 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800